Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Type of study
Publication year range
1.
Appl Microbiol Biotechnol ; 106(9-10): 3657-3667, 2022 May.
Article in English | MEDLINE | ID: mdl-35579683

ABSTRACT

Oxidases are a group of oxidoreductases and need molecular oxygen in the catalytic process. Vitreoscilla hemoglobin (VHb) can improve the growth and productivity of host cells under hypoxic conditions, rendering it attractive for industrial application. In this work, we demonstrated the addition of immobilized VHb increased the catalytic activity of immobilized D-amino acid oxidase of Trigonopsis variabilis by two-fold when catalyzing cephalosporin C under oxygen-limited conditions. A similar increase of activities was observed in glucose oxidase, alcohol oxidase, and p-hydroxymandelate synthase by adding free VHb or immobilized VHb under hypoxic conditions. When L-glutamate oxidase was used to catalyze L-glutamate to produce α-ketoglutarate, the yield increased from 80.6 to 96.9% by fusing VHb with L-glutamate oxidase. Results demonstrated that the addition of free VHb, immobilized VHb, or fused VHb could increase the catalytic efficiency of oxidases, which was considered by increasing the concentration of the microenvironmental oxygen. Thus, VHb may become a potential additive agent to promote the efficiency of oxidases on industrial scale . KEY POINTS: • First time confirmation of facilitation of VHb on several industrial oxidases in vitro • VHb functions under hypoxic conditions rather than oxygen-enriched conditions • VHb functions in vitro in the form of free, immobilized protein and fusion enzyme.


Subject(s)
Oxidoreductases , Vitreoscilla , Bacterial Proteins/metabolism , Escherichia coli/metabolism , Hemoglobins/chemistry , Hemoglobins/metabolism , Oxidoreductases/metabolism , Oxygen/metabolism , Truncated Hemoglobins/genetics , Truncated Hemoglobins/metabolism , Vitreoscilla/genetics
2.
J Appl Microbiol ; 133(2): 273-286, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35294082

ABSTRACT

Mandelic acid and its derivatives are an important class of chemical synthetic blocks, which is widely used in drug synthesis and stereochemistry research. In nature, mandelic acid degradation pathway has been widely identified and analysed as a representative pathway of aromatic compounds degradation. The most studied mandelic acid degradation pathway from Pseudomonas putida consists of mandelate racemase, S-mandelate dehydrogenase, benzoylformate decarboxylase, benzaldehyde dehydrogenase and downstream benzoic acid degradation pathways. Because of the ability to catalyse various reactions of aromatic substrates, pathway enzymes have been widely used in biocatalysis, kinetic resolution, chiral compounds synthesis or construction of new metabolic pathways. In this paper, the physiological significance and the existing range of the mandelic acid degradation pathway were introduced first. Then each of the enzymes in the pathway is reviewed one by one, including the researches on enzymatic properties and the applications in biotechnology as well as efforts that have been made to modify the substrate specificity or improving catalytic activity by enzyme engineering to adapt different applications. The composition of the important metabolic pathway of bacterial mandelic acid degradation pathway as well as the researches and applications of pathway enzymes is summarized in this review for the first time.


Subject(s)
Mandelic Acids , Pseudomonas putida , Biotechnology , Kinetics , Mandelic Acids/chemistry , Mandelic Acids/metabolism , Oxidoreductases/metabolism
3.
Crit Rev Biotechnol ; 42(6): 838-855, 2022 Sep.
Article in English | MEDLINE | ID: mdl-34779326

ABSTRACT

Eicosapentaenoic Acid (EPA) is an essential ω-3 polyunsaturated fatty acid for human health. Currently, high-quality EPA production is largely dependent on the extraction of fish oil, but this unsustainable approach cannot meet its rising market demand. Biotechnological approaches for EPA production from microorganisms have received increasing attention due to their suitability for large-scale production and independence of the seasonal or climate restrictions. This review summarizes recent research on different microorganisms capable of producing EPA, such as microalgae, bacteria, and fungi, and introduces the different EPA biosynthesis pathways. Notably, some novel engineering strategies have been applied to endow and improve the abilities of microorganisms to synthesize EPA, including the construction and optimization of the EPA biosynthesis pathway, an increase in the acetyl-CoA pool supply, the increase of NADPH and the inhibition of competing pathways. This review aims to provide an updated summary of EPA production.


Subject(s)
Fatty Acids, Omega-3 , Microalgae , Biosynthetic Pathways , Eicosapentaenoic Acid/metabolism , Fatty Acids, Omega-3/metabolism , Metabolic Engineering , Microalgae/metabolism
4.
Appl Microbiol Biotechnol ; 105(16-17): 6183-6197, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34402938

ABSTRACT

Research on the roles of the bacteria in tumor development and progression is a rapidly emerging field. Increasing evidence links bacteria with the modification of the tumor immune microenvironment, which greatly influences the antitumor response. In view of the individual immune effects of various bacteria in various tumors, developing personalized bacteria-modulating therapy may be a key to successful antitumor treatment. This review emphasizes the critical role of the bacteria in immune regulation, including both the tumor bacteria and gut bacteria. Aiming at tumor-related bacteria, we focus on various precise modulation strategies and discuss their impact and potential for tumor suppression. Finally, engineered bacteria with tumor-targeting ability could achieve precise delivery of various payloads into tumors, acting as a precision tool. Therefore, a precise tumor-related bacteria therapy may be a promising approach to suppress the development of tumors, as well as an adjuvant therapy to improve the antitumor efficacy of other approaches. KEY POINTS: • The mini-review updates the knowledge on complex effect of bacteria in TME. • Insight into the interaction and adjustment of bacteria in gut for TME. • Prospects and limitations of bacteria-related personalized therapy in the clinical anticancer therapy.


Subject(s)
Neoplasms , Bacteria , Combined Modality Therapy , Humans , Immunotherapy , Neoplasms/drug therapy , Tumor Microenvironment
5.
Front Bioeng Biotechnol ; 9: 661694, 2021.
Article in English | MEDLINE | ID: mdl-34164382

ABSTRACT

Short- and medium-chain volatile esters with flavors and fruity fragrances, such as ethyl acetate, butyl acetate, and butyl butyrate, are usually value-added in brewing, food, and pharmacy. The esters can be naturally produced by some microorganisms. As ester-forming reactions are increasingly deeply understood, it is possible to produce esters in non-natural but more potential hosts. Clostridia are a group of important industrial microorganisms since they can produce a variety of volatile organic acids and alcohols with high titers, especially butanol and butyric acid through the CoA-dependent carbon chain elongation pathway. This implies sufficient supplies of acyl-CoA, organic acids, and alcohols in cells, which are precursors for ester production. Besides, some Clostridia could utilize lignocellulosic biomass, industrial off-gas, or crude glycerol to produce other branched or straight-chain alcohols and acids. Therefore, Clostridia offer great potential to be engineered to produce short- and medium-chain volatile esters. In the review, the efforts to produce esters from Clostridia via in vitro lipase-mediated catalysis and in vivo alcohol acyltransferase (AAT)-mediated reaction are comprehensively revisited. Besides, the advantageous characteristics of several Clostridia and clostridial consortia for bio-ester production and the driving force of synthetic biology to clostridial chassis development are also discussed. It is believed that synthetic biotechnology should enable the future development of more effective Clostridia for ester production.

6.
Front Microbiol ; 12: 654058, 2021.
Article in English | MEDLINE | ID: mdl-33897668

ABSTRACT

Corynebacterium glutamicum has been considered a promising synthetic biological platform for biomanufacturing and bioremediation. However, there are still some challenges in genetic manipulation of C. glutamicum. Recently, more and more genetic parts or elements (replicons, promoters, reporter genes, and selectable markers) have been mined, characterized, and applied. In addition, continuous improvement of classic molecular genetic manipulation techniques, such as allelic exchange via single/double-crossover, nuclease-mediated site-specific recombination, RecT-mediated single-chain recombination, actinophages integrase-mediated integration, and transposition mutation, has accelerated the molecular study of C. glutamicum. More importantly, emerging gene editing tools based on the CRISPR/Cas system is revolutionarily rewriting the pattern of genetic manipulation technology development for C. glutamicum, which made gene reprogramming, such as insertion, deletion, replacement, and point mutation, much more efficient and simpler. This review summarized the recent progress in molecular genetic manipulation technology development of C. glutamicum and discussed the bottlenecks and perspectives for future research of C. glutamicum as a distinctive microbial chassis.

9.
ACS Synth Biol ; 9(7): 1897-1906, 2020 07 17.
Article in English | MEDLINE | ID: mdl-32627539

ABSTRACT

l-Proline is an important amino acid that has various industrial applications. Industrial l-proline-producing strains are obtained by the mutagenesis of Corynebacterium glutamicum. In this study, the optimized C. glutamicum genome-editing tools were further applied in the de novo construction of a hyper-l-proline-producing strain. Overexpression of a feedback inhibition-resistant γ-glutamic kinase mutant ProBG149K, deletion of a proline dehydrogenase to block l-proline degradation, overexpression of glutamate dehydrogenase to increase glutamate synthesis flux, the mutation of 6-phosphate gluconate dehydrogenase and glucose-6-phosphate-dehydrogenase in the pentose phosphate pathway to enhance NADPH supply, the deletion of pyruvate aminotransferase to decrease the byproduct l-alanine synthesis, and weakening of α-ketoglutarate dehydrogenase to regulate the TCA cycle were combined to obtain ZQJY-9. ZQJY-9 produced 19.68 ± 0.22 g/L of l-proline in flask fermentation and was also demonstrated at the 3 L bioreactor level by fed-batch fermentation producing 120.18 g/L of l-proline at 76 h with the highest productivity of 1.581 g/L/h.


Subject(s)
Bacterial Proteins/biosynthesis , Corynebacterium glutamicum/genetics , Corynebacterium glutamicum/metabolism , Metabolic Engineering/methods , Proline/biosynthesis , Bioreactors , Citric Acid Cycle , Fermentation , Gene Editing/methods , Mutagenesis , NADP/metabolism , Pentose Phosphate Pathway/genetics , Phosphogluconate Dehydrogenase/metabolism
10.
ACS Synth Biol ; 9(8): 1998-2008, 2020 08 21.
Article in English | MEDLINE | ID: mdl-32551502

ABSTRACT

Controlling the copy number of gene expression cassettes is an important strategy to engineer bacterial cells into high-efficiency biocatalysts. Current strategies mostly use plasmid vectors, but multicopy plasmids are often genetically unstable, and their copy numbers cannot be precisely controlled. The integration of expression cassettes into a bacterial chromosome has advantages, but iterative integration is laborious, and it is challenging to obtain a library with varied gene doses for phenotype characterization. Here, we demonstrated that multicopy chromosomal integration using CRISPR-associated transposases (MUCICAT) can be achieved by designing a crRNA to target multicopy loci or a crRNA array to target multiple loci in the Escherichia coli genome. Within 5 days without selection pressure, E. coli strains carrying cargos with successively increasing copy numbers (up to 10) were obtained. Recombinant MUCICAT E. coli containing genomic multicopy glucose dehydrogenase expression cassettes showed 2.6-fold increased expression of this important industrial enzyme compared to E. coli harboring the conventional protein-expressing plasmid pET24a. Successful extension of MUCICAT to Tatumella citrea further demonstrated that MUCICAT may be generally applied to many bacterial species.


Subject(s)
Chromosomes, Bacterial/metabolism , Clustered Regularly Interspaced Short Palindromic Repeats/genetics , Escherichia coli/genetics , Transposases/genetics , Escherichia coli/metabolism , Gene Dosage , Gene Expression , Glucose 1-Dehydrogenase/genetics , Glucose 1-Dehydrogenase/metabolism , Mutagenesis, Insertional , Plasmids/genetics , Plasmids/metabolism
11.
Rev Sci Instrum ; 91(1): 015006, 2020 Jan 01.
Article in English | MEDLINE | ID: mdl-32012606

ABSTRACT

A Mach-Zehnder interferometer for measurement of temperature is proposed and experimentally demonstrated, which consists of two sections of single mode fiber (SMF) and a section of thin core fiber spliced between the two SMFs. The two welding areas are heated and stretched to improve the split and recombination of light. The wavelength of the resonant dip will shift when temperature varies due to the thermo-optic and thermal expansion effect. The experimental results show that a temperature sensitivity of 65 pm/°C with a linear correlation coefficient of 0.996 can be achieved in a temperature range from 25 °C to 80 °C. Due to its ease of manufacture, low cost, and high sensitivity, the fiber optic temperature sensor is suitable for temperature measurement applications.

12.
Microb Cell Fact ; 17(1): 41, 2018 Mar 13.
Article in English | MEDLINE | ID: mdl-29534717

ABSTRACT

BACKGROUND: The soil bacterium Pseudomonas putida KT2440 is a "generally recognized as safe"-certified strain with robust property and versatile metabolism. Thus, it is an ideal candidate for synthetic biology, biodegradation, and other biotechnology applications. The known genome editing approaches of Pseudomonas are suboptimal; thus, it is necessary to develop a high efficiency genome editing tool. RESULTS: In this study, we established a fast and convenient CRISPR-Cas9 method in P. putida KT2440. Gene deletion, gene insertion and gene replacement could be achieved within 5 days, and the mutation efficiency reached > 70%. Single nucleotide replacement could be realized, overcoming the limitations of protospacer adjacent motif sequences. We also applied nuclease-deficient Cas9 binding at three locations upstream of enhanced green fluorescent protein (eGFP) for transcriptional inhibition, and the expression intensity of eGFP reduced to 28.5, 29.4, and 72.1% of the control level, respectively. Furthermore, based on this CRISPR-Cas9 system, we also constructed a CRISPR-Cpf1 system, which we validated for genome editing in P. putida KT2440. CONCLUSIONS: In this research, we established CRISPR based genome editing and regulation control systems in P. putida KT2440. These fast and efficient approaches will greatly facilitate the application of P. putida KT2440.


Subject(s)
CRISPR-Cas Systems , Gene Editing , Pseudomonas putida/genetics , Endonucleases/metabolism , Gene Deletion , Gene Expression , Green Fluorescent Proteins , Mutagenesis, Insertional , Pseudomonas putida/metabolism
13.
Chembiochem ; 17(1): 56-64, 2016 Jan 01.
Article in English | MEDLINE | ID: mdl-26662025

ABSTRACT

L-Aspartate-ß-semialdehyde dehydrogenase (ASADH) is a key enzyme in the aspartate pathway. In bacteria, ASADH is highly specific for the cofactor NADP(+) rather than NAD(+). Limited information on cofactor utilization is available, and neither the wild-type protein nor the available mutants could utilize NAD(+) efficiently. In this study, we identified several residues crucial for cofactor utilization by Escherichia coli ASADH (ecASADH) by mutating residues within the cofactor binding center. Among the investigated mutants, ecASADH-Q350N and ecASADH-Q350N/H171A, which exhibited markedly improved NAD(+) utilization, were further investigated by various biochemical approaches and molecular modeling. Relative to the wild type, the two mutants showed approximately 44-fold and 66-fold increases, respectively, in the constant kcat /Km of NAD(+). As desired, they could also utilize NADH efficiently to synthesize l-homoserine in cascade reactions in vitro.


Subject(s)
Aspartate-Semialdehyde Dehydrogenase/genetics , Aspartate-Semialdehyde Dehydrogenase/metabolism , Escherichia coli/enzymology , NAD/metabolism , Aspartate-Semialdehyde Dehydrogenase/isolation & purification , Binding Sites , Enzyme Activation/genetics , Escherichia coli/cytology , Escherichia coli/metabolism , Models, Molecular , Mutagenesis
SELECTION OF CITATIONS
SEARCH DETAIL
...